JP7636801B2 - ハイドロゲル微粒子の調整可能な分解 - Google Patents
ハイドロゲル微粒子の調整可能な分解 Download PDFInfo
- Publication number
- JP7636801B2 JP7636801B2 JP2021571880A JP2021571880A JP7636801B2 JP 7636801 B2 JP7636801 B2 JP 7636801B2 JP 2021571880 A JP2021571880 A JP 2021571880A JP 2021571880 A JP2021571880 A JP 2021571880A JP 7636801 B2 JP7636801 B2 JP 7636801B2
- Authority
- JP
- Japan
- Prior art keywords
- microparticles
- hydrogel
- cells
- cell
- microparticle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962858578P | 2019-06-07 | 2019-06-07 | |
| US62/858,578 | 2019-06-07 | ||
| PCT/US2020/036361 WO2020247776A1 (en) | 2019-06-07 | 2020-06-05 | Tunable degradation in hydrogel microparticles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534787A JP2022534787A (ja) | 2022-08-03 |
| JP2022534787A5 JP2022534787A5 (https=) | 2023-05-25 |
| JP7636801B2 true JP7636801B2 (ja) | 2025-02-27 |
Family
ID=73652291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021571880A Active JP7636801B2 (ja) | 2019-06-07 | 2020-06-05 | ハイドロゲル微粒子の調整可能な分解 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12551449B2 (https=) |
| EP (1) | EP3980075A4 (https=) |
| JP (1) | JP7636801B2 (https=) |
| KR (1) | KR20220019261A (https=) |
| CN (2) | CN113924122B (https=) |
| AU (1) | AU2020288650B2 (https=) |
| CA (1) | CA3134372A1 (https=) |
| IL (1) | IL295911A (https=) |
| WO (1) | WO2020247776A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230129007A (ko) * | 2020-10-28 | 2023-09-05 | 뉴욕 쏘사이어티 포 더 릴리프 어브 더 럽쳐드 앤드 크리플드 메인테이닝 더 하스피틀 포 스페셜 설져리 | 조직 손상 및 상처에서 영양 유지 및 노폐물 제거를 위한 방법 및 조성물 |
| KR20230119170A (ko) * | 2020-12-09 | 2023-08-16 | 리카다, 엘엘씨 | 하이드로겔 마이크로입자 기반 윤활제 |
| WO2022170012A1 (en) * | 2021-02-08 | 2022-08-11 | The Trustees Of Indiana University | Synthesis of peg-based thiol-norbornene hydrogels with tunable hydroylitic degradation properties |
| KR20240018511A (ko) * | 2021-05-26 | 2024-02-13 | 조지아 테크 리서치 코포레이션 | 가수분해성 하이드로겔 및 이의 용도 |
| US20250001049A1 (en) * | 2021-10-15 | 2025-01-02 | Prohibix Llc | Bulking and collagen stimulating hydrogel compositions |
| WO2023106271A1 (ja) * | 2021-12-06 | 2023-06-15 | 株式会社リコー | ハイドロゲル、インクジェット用インク、細胞培養体の作製方法、細胞含有ゲル粒子及びその製造方法 |
| US20240026088A1 (en) | 2022-07-19 | 2024-01-25 | CellDrop Biosciences, Inc. | Hydrogel Particle Encapsulation and Suspension Media Removal |
| WO2024173668A1 (en) * | 2023-02-17 | 2024-08-22 | Ocular Therapeutix, Inc. | Biodegradable microparticles for sustained drug delivery, methods of preparation and use thereof |
| KR102844193B1 (ko) * | 2024-02-07 | 2025-08-13 | 주식회사 알데바 | 지방 조직 유사 구조체 형성용 조성물 및 지방 조직 유사 구조체의 제조방법 |
| US20250319098A1 (en) * | 2024-02-21 | 2025-10-16 | Vitalte Lifesciences Inc. | Hormone replenishment method with a hydrogel polymer |
| CN119258009A (zh) * | 2024-09-30 | 2025-01-07 | 山东大学 | 一种促进dha胞内降脂的水凝胶材料及其制备方法与应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080193536A1 (en) | 2006-08-14 | 2008-08-14 | Alireza Khademhosseini | Cell-Laden Hydrogels |
| US20150071997A1 (en) | 2013-09-09 | 2015-03-12 | Georgia Tech Research Corporation | Microgels for Encapsulation of Cells and Other Biologic Agents |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7276251B2 (en) | 1997-04-01 | 2007-10-02 | Lg Life Sciences, Ltd., Inc. | Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| WO2002030481A1 (en) | 2000-10-10 | 2002-04-18 | Massachusetts Institute Of Technology | Cell delivery using controllably degradable mesh-gel constructs |
| CN101448527B (zh) | 2006-05-19 | 2013-12-18 | 香港大学 | 细胞-基质微球,制备方法和应用 |
| US20100069781A1 (en) * | 2008-04-15 | 2010-03-18 | Johansen Jerald A | Device and method for accessing and treating ducts of mammary glands |
| KR101101321B1 (ko) | 2008-11-03 | 2012-01-02 | 주식회사 엠씨티티 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
| CA2769162C (en) * | 2009-07-31 | 2017-12-05 | Ascendis Pharma As | Biodegradable polyethylene glycol based water-insoluble hydrogels |
| US10647959B2 (en) | 2011-04-27 | 2020-05-12 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
| SG11201500188YA (en) * | 2012-08-08 | 2015-02-27 | Univ Nanyang Tech | Methods of manufacturing hydrogel microparticles having living cells, and compositions for manufacturing a scaffold for tissue engineering |
| CN106470666B (zh) * | 2014-06-04 | 2021-01-01 | 立卡达有限责任公司 | 微囊封装技术及其产品 |
| WO2015187098A1 (en) | 2014-06-05 | 2015-12-10 | Agency For Science, Technology And Research | Material and structures for cell delivery |
| US20160297131A1 (en) | 2015-04-07 | 2016-10-13 | The Texas A&M University System | Hydrogel Microparticles via Soft Robotics Micromold (SRM) for In Vitro Cell Culture |
| US10137082B2 (en) | 2016-08-22 | 2018-11-27 | Washington University | Hydrogel microparticle scaffold with gradients of degradability and methods thereof |
| JP2022513378A (ja) | 2018-10-26 | 2022-02-07 | テサラ・セラピューティクス・ピーティーワイ・リミテッド | 神経系細胞療法 |
| US20220175666A1 (en) | 2019-03-21 | 2022-06-09 | Anterogen Co., Ltd. | Injection formulation composition containing mesenchymal stem cell-hydrogel and method for preparing, freezing and defrosting same |
| EP4284338A4 (en) | 2021-02-01 | 2024-12-04 | The Regents Of The University Of Colorado, A Body Corporate | COMPOSITIONS AND METHODS OF MAKING AND USING HYBRID NETWORK HYDROGELS |
-
2020
- 2020-06-05 CA CA3134372A patent/CA3134372A1/en active Pending
- 2020-06-05 JP JP2021571880A patent/JP7636801B2/ja active Active
- 2020-06-05 KR KR1020227000238A patent/KR20220019261A/ko active Pending
- 2020-06-05 CN CN202080041898.0A patent/CN113924122B/zh active Active
- 2020-06-05 EP EP20817813.7A patent/EP3980075A4/en active Pending
- 2020-06-05 US US17/617,086 patent/US12551449B2/en active Active
- 2020-06-05 IL IL295911A patent/IL295911A/en unknown
- 2020-06-05 CN CN202511015399.5A patent/CN120938958A/zh active Pending
- 2020-06-05 AU AU2020288650A patent/AU2020288650B2/en active Active
- 2020-06-05 WO PCT/US2020/036361 patent/WO2020247776A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080193536A1 (en) | 2006-08-14 | 2008-08-14 | Alireza Khademhosseini | Cell-Laden Hydrogels |
| US20150071997A1 (en) | 2013-09-09 | 2015-03-12 | Georgia Tech Research Corporation | Microgels for Encapsulation of Cells and Other Biologic Agents |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020288650B2 (en) | 2025-12-11 |
| KR20220019261A (ko) | 2022-02-16 |
| US12551449B2 (en) | 2026-02-17 |
| EP3980075A1 (en) | 2022-04-13 |
| IL295911A (en) | 2022-10-01 |
| AU2020288650A1 (en) | 2021-12-09 |
| EP3980075A4 (en) | 2023-07-12 |
| JP2022534787A (ja) | 2022-08-03 |
| CN113924122B (zh) | 2025-08-12 |
| CN120938958A (zh) | 2025-11-14 |
| CN113924122A (zh) | 2022-01-11 |
| WO2020247776A1 (en) | 2020-12-10 |
| CA3134372A1 (en) | 2020-12-10 |
| US20220233454A1 (en) | 2022-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7636801B2 (ja) | ハイドロゲル微粒子の調整可能な分解 | |
| JP6881877B2 (ja) | 細胞の封入および細胞集合体のための多層ヒドロゲルカプセル | |
| Yang et al. | Injectable chitin hydrogels with self-healing property and biodegradability as stem cell carriers | |
| RU2542509C2 (ru) | Микрокапсульный препарат на основе альгината-ацильных производных хитозана, его получение и применение | |
| CA2625875C (en) | Encapsulation system | |
| CN101227913B (zh) | 自胶凝的藻酸盐体系及其用途 | |
| DE69333512T2 (de) | Gele zur verkapselung von biologischen materialien | |
| Hamilton et al. | Hyaluronic acid hydrogel microspheres for slow release stem cell delivery | |
| JP6566970B2 (ja) | マイクロカプセル化技術及びその生成物 | |
| US6281341B1 (en) | Hetero-polysaccharide conjugate and methods of making and using the same | |
| JP2022534787A5 (https=) | ||
| Xue et al. | Controllable fabrication of alginate/poly-L-ornithine polyelectrolyte complex hydrogel networks as therapeutic drug and cell carriers | |
| MXPA06006930A (es) | Uso de matrices de alginato para controlar la proliferacion celular. | |
| CA3054277A1 (en) | Cell or tissue embedding device | |
| CN104368046B (zh) | 一种纤维增强型载药水凝胶人工角膜裙边支架及其制备方法 | |
| CN116376816A (zh) | 一种微球共混生物3d打印凝胶材料及其制备方法和应用 | |
| JP2023534787A (ja) | 膨潤性ゼラチン組成物 | |
| EP4582439A1 (en) | Method for obtainingmethod for obtaining a porous injectable scaffold based on similar biopolymers with different melting temperatures | |
| Joshy et al. | Alginate Properties, Pharmaceutical and Tissue Engineering Applications | |
| Morrison | Synthesis and Characterization of Double Network Hydrogels Containing Norbornene-Modified Carboxymethyl Cellulose and Cellulose Nanofibrils | |
| EA048072B1 (ru) | Способная к набуханию желатиновая фармацевтическая композиция, набухшая желатиновая фармацевтическая композиция, способы их получения и варианты их применения | |
| Lv et al. | Microcapsules for Cell Transplantation: Design, Preparation, and Application | |
| HK1173180A (en) | Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230517 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230517 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240604 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240903 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20241101 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241202 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250107 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250206 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7636801 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |